7Baggers

GitLab Quarterly Cash Flow Statements Chart

Quarterly
 | 
Annual
 
 Stock-Based Compensation  
 Operating Cash Flow  
 Investing Cash Flow  
 Financing Cash Flow  
 Free Cash Flow  
 Capital Expenditure  
20220131 20220430 20220731 20221031 20230131 20230430 20230731 20231031 20240131 20240430 20240731 20241031 20250131 20250430 20250731 -178.09-137.46-96.83-56.2-15.5825.0565.68106.3Milllion

GitLab Quarterly Cash Flow Statements Table

Quarterly
 | 
Annual
 
Unit: USD2025-07-31 2025-04-30 2025-01-31 2024-10-31 2024-07-31 2024-04-30 2024-01-31 2023-10-31 2023-07-31 2023-04-30 2023-01-31 2022-10-31 2022-07-31 2022-04-30 2022-01-31 
                 
  cash flows from operating activities:               
  net income-9,996,000 -36,258,000 5,227,000 28,267,000 12,274,000 -54,887,000 -37,571,000 -286,355,000 -51,208,000 -52,899,000 -42,121,000 -50,465,000 -61,497,000 -26,613,000 -46,764,000 
  adjustments to reconcile net income to net cash from operating activities:               
  stock-based compensation expense54,284,000 55,827,000 46,636,000 48,042,000 48,969,000 42,252,000 43,017,000 41,334,000 46,368,000 32,330,000 33,641,000 33,708,000 37,747,000 17,471,000 12,767,000 
  change in fair value of acquisition related contingent consideration             
  charitable donation of common stock1,787,000 1,739,000 2,956,000 2,957,000 2,957,000 2,957,000 2,675,000 2,675,000 2,675,000 2,675,000      
  amortization of intangible assets2,015,000 2,020,000 2,195,000 2,511,000 2,333,000 1,087,000 521,000 521,000 546,000 579,000 595,000 591,000 595,000 581,000 414,000 
  depreciation expense759,000 556,000 499,000 680,000 744,000 937,000 1,039,000 1,123,000 1,114,000 1,092,000 1,033,000 912,000 728,000 558,000  
  amortization of deferred contract acquisition costs13,370,000 13,899,000 14,064,000 12,704,000 11,837,000 11,109,000 12,397,000 10,447,000 10,070,000 10,549,000 12,265,000 11,075,000 10,805,000 10,813,000 9,813,000 
  net amortization of premiums or discounts on short-term investments-2,609,000 -2,996,000 -3,813,000 -3,792,000 -4,241,000 -4,900,000 -5,988,000 -5,867,000 -4,898,000 -3,596,000 -2,731,000 -2,053,000    
  unrealized foreign exchange gain  -4,084,000 -5,184,000 -803,000 545,000 4,396,000 -573,000 1,087,000 -262,000      
  other non-cash expense192,000 208,000 162,000    1,013,000       -268,000 325,000 
  changes in assets and liabilities:               
  accounts receivable3,859,000 65,928,000 -67,991,000 -32,883,000 -29,847,000 31,072,000 -31,050,000 -30,572,000 20,441,000 4,840,000 -32,006,000 -8,595,000 -22,242,000 8,674,000 -20,873,000 
  prepaid expenses and other current assets1,219,000 1,527,000 5,926,000 -10,773,000 2,917,000 10,354,000 -15,671,000 -3,935,000 -2,161,000 -2,087,000 -3,589,000 168,000 -3,330,000 -2,158,000 -4,846,000 
  deferred contract acquisition costs-12,304,000 -8,126,000 -22,421,000 -14,751,000 -12,415,000 -8,540,000 -21,340,000 -13,623,000 -9,640,000 -8,497,000 -15,410,000 -11,935,000    
  other non-current assets-198,000 379,000 -1,034,000 1,348,000 -78,000 -419,000 865,000         
  accounts payable-472,000 3,586,000 5,472,000 -1,317,000 14,000 1,336,000 -3,219,000 799,000 1,135,000 -2,158,000 -1,106,000 865,000 -272,000 800,000 91,000 
  accrued expenses and other current liabilities-14,257,000 9,979,000 -11,665,000 -220,071,000 -41,250,000 19,617,000 12,436,000 244,674,000 -1,606,000 2,789,000 1,370,000 3,159,000 -1,479,000 1,569,000 12,934,000 
  accrued compensation and benefits2,021,000 -13,084,000 13,558,000 -1,913,000 6,250,000 -13,152,000 12,331,000 231,000 7,732,000 -5,121,000 3,457,000 1,530,000 3,926,000 -20,606,000 15,943,000 
  deferred revenue8,284,000 1,205,000 74,240,000 19,665,000 19,286,000 -4,448,000 50,189,000 17,983,000 2,792,000 8,383,000 32,803,000 22,651,000 10,862,000 6,687,000 37,605,000 
  other non-current liabilities346,000 12,000 3,295,000 -2,985,000 -10,889,000 2,806,000 -10,821,000 14,270,000        
  net cash from operating activities49,369,000 106,302,000 63,222,000 -177,028,000 11,697,000 38,138,000 24,853,000 -5,961,000 27,109,000 -10,961,000 -11,720,000 -1,197,000 -36,335,000 -28,156,000 -1,094,000 
  capex-2,904,000 -912,000 -1,157,000 -1,057,000 -851,000 -700,000 -329,000 -736,000 -277,000 -256,000 -1,052,000 -1,784,000 -1,360,000 -1,874,000 
  free cash flows46,465,000 105,390,000 62,065,000 -178,085,000 10,846,000 37,438,000 24,524,000 -6,697,000 26,832,000 -11,217,000 -12,772,000 -2,981,000 -37,695,000 -30,030,000 -1,094,000 
  cash flows from investing activities:               
  purchases of short-term investments-237,946,000 -245,952,000 -204,304,000 -240,136,000 -118,866,000 -144,392,000 -242,021,000 -238,680,000 -276,132,000 -58,864,000 -189,671,000 -111,287,000 -473,303,000 -47,361,000 
  proceeds from maturities of short-term investments184,280,000 163,606,000 183,520,000 148,763,000 121,412,000 254,687,000 207,028,000 253,995,000 189,484,000 83,500,000 108,925,000 72,670,000 50,031,000  
  proceeds from sales of short-term investments1,367,000              
  purchases of property and equipment-2,904,000 -912,000 -1,157,000 -1,057,000 -851,000 -700,000 -329,000 -736,000 -277,000 -256,000 -1,052,000 -1,784,000 -1,360,000 -1,874,000  
  payments for business combination, net of cash acquired  -20,210,000          
  payments for asset acquisition  -346,000            
  other investing activities             
  net cash from investing activities-56,570,000 -81,891,000 -21,941,000 -92,776,000 -5,162,000 89,385,000 -35,772,000 14,579,000 -89,425,000 24,380,000 -81,798,000 -40,401,000 -474,663,000 -8,824,000 46,136,000 
  cash flows from financing activities:               
  proceeds from the issuance of common stock upon exercise of stock options, including early exercises, net of repurchases3,947,000 3,328,000 6,069,000 7,822,000 4,980,000 5,093,000 9,810,000 4,715,000 10,264,000 7,513,000 7,061,000 6,143,000 5,994,000 5,317,000 10,780,000 
  issuance of common stock under employee stock purchase plan  5,624,000   5,182,000   4,824,000    
  net cash from financing activities12,351,000 3,328,000 11,693,000 2,922,000 12,912,000 5,093,000 14,992,000 4,715,000 18,015,000 7,513,000 11,885,000 7,059,000 34,815,000 43,723,000 9,597,000 
  impact of foreign exchange on cash and cash equivalents502,000 331,000 -1,957,000 4,898,000 -1,153,000 -290,000 -1,386,000 -1,249,000 -907,000 -401,000 4,866,000 -4,049,000 -549,000 -3,926,000  
  net increase in cash and cash equivalents5,652,000 28,070,000   18,294,000 132,326,000    20,531,000 -76,767,000   2,817,000  
  cash and cash equivalents at beginning of period227,649,000            
  cash and cash equivalents at end of period5,652,000 255,719,000 51,017,000 -261,984,000            
  supplemental disclosure of cash flow information:               
  cash paid (refunds) for income taxes-381,000 -1,295,000              
  supplemental disclosure of non-cash investing and financing activities:               
  unpaid property and equipment in accounts payable and accrued expenses               
  unpaid direct transaction costs related to the asset acquisition in accrued expenses               
  unrealized foreign exchange loss 9,901,000              
  vesting of early exercised stock options 38,000    98,000 204,000 221,000 292,000 517,000 600,000 1,146,000 814,000 2,146,000 1,787,000 
  unpaid property and equipment in accounts payable 135,000              
  gain from deconsolidation of arch, formerly meltano               
  income from equity method investment      776,000 940,000 1,161,000 947,000 942,000 957,000 1,034,000 256,000  
  impairment of equity method investment               
  deconsolidation of arch, formerly meltano               
  escrow payment related to business combination, after acquisition date             
  contributions received from noncontrolling interests, net of issuance costs          4,053,000 22,145,000 35,528,000  
  settlement of acquisition related contingent cash consideration              
  net decrease in cash and cash equivalents  51,017,000     12,084,000        
  cash paid for income taxes related to the bilateral advance pricing agreement              
  other cash paid for income taxes               
  acquisition measurement period adjustment               
  reconciliation of cash, cash equivalents and restricted cash within the consolidated balance sheets to the amounts shown in the statements of cash flows above:               
  cash and cash equivalents      2,687,000 12,084,000 -42,708,000 315,933,000 -76,767,000 -38,588,000 -476,732,000 887,489,000  
  restricted cash, included in prepaid expenses and other current assets         2,500,000      
  total cash, cash equivalents and restricted cash      2,687,000 12,084,000 -45,208,000 318,433,000 -76,767,000 -38,588,000 -476,732,000 889,989,000  
  other non-cash income    -111,000 412,000   -44,000 -59,000  -30,000    
  cash paid for income taxes    792,000 1,011,000 888,000 1,828,000 3,121,000 1,066,000 311,000 218,000 136,000 173,000 199,000 
  cash, cash equivalents, and restricted cash at beginning of period     287,996,000 297,902,000 887,172,000  
  cash, cash equivalents, and restricted cash at end of period     420,322,000 2,687,000 12,084,000 -45,208,000 318,433,000 -76,767,000 -38,588,000 -476,732,000 889,989,000  
  right-of-use assets obtained in exchange for new operating lease liabilities     284,000          
  gain from the fair value change of acquisition related contingent consideration               
  payments for business combination, net of cash acquired and consideration withheld in an escrow               
  proceeds from initial public offering, net of underwriting discounts              
  proceeds from warrants exercised               
  repurchase of common stock in a tender offer               
  partial settlement of acquisition related contingent cash consideration              
  payments of deferred offering costs              -1,269,000 
  cash donations              
  issuance of common stock upon conversion of preferred stock               
  unpaid property and equipment in accrued expenses             33,000  
  unpaid deferred offering costs              -1,269,000 
  restricted cash, included in other non-current assets               
  gain from deconsolidation of meltano inc.          -17,798,000  
  deconsolidation of meltano inc.          -9,620,000  
  reconciliation of cash, cash equivalents and restricted cash within the condensed consolidated balance sheets to the amounts shown in the condensed consolidated statements of cash flows above:               
  other long-term assets        -419,000 -302,000 962,000 -650,000 2,761,000 -61,000 -254,000 
  other long-term liabilities         -164,000 -1,174,000 -576,000 -3,115,000 2,419,000 -1,496,000 
  proceeds from short-term borrowings from an investor in jihu               
  unpaid issuance costs related to capital contributions from noncontrolling interest holders             744,000  
  restricted cash, included in other long-term assets             2,500,000  
  operating lease non-cash expense               
  unrealized foreign exchange (gain) loss          354,000 -2,509,000 -1,341,000 -231,000 637,000 
  payments for asset acquisitions               
  reconciliation of cash, cash equivalents and restricted cash within the consolidated balance sheets to the amounts shown in the consolidated statements of cash flows above:               
  reconciliation of cash, cash equivalents and restricted cash within the condensed consolidated balance sheets to the amounts shown in the consolidated statements of cash flows above:               
  restricted cash, current included in prepaid expenses and other current assets              
  costs deferred related to contract acquisition             -10,249,000 -17,933,000 
  proceeds from short-term borrowings from a potential investor in jihu             2,878,000  
  net proceeds from series e preferred stock financing               
  contributions received from noncontrolling interests              
  impact of foreign exchange on cash, cash equivalents and restricted cash               
  net increase in cash, cash equivalents and restricted cash               
  cash, cash equivalents and restricted cash at beginning of period               
  cash, cash equivalents and restricted cash at end of period               
  intangible assets acquisitions, net of cash acquired               
  repurchase of common stock               
  net increase in cash               
  cash and cash equivalents, beginning of period               
  cash and cash equivalents, end of period               
  conversion of convertible preferred stock to common stock upon initial public offering               

We provide you with 20 years of cash flow statements for GitLab stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of GitLab stock. Explore the full financial landscape of GitLab stock with our expertly curated income statements.

The information provided in this report about GitLab stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.